Sage Journals: Discover world-class research

Retricted access

Research article

First published 2024-02

Establishment of Anti-Dog Programmed Cell Death Ligand 1 Monoclonal Antibodies for Immunohistochemistry

Tsunenori Ouchida, Hiroyuki Suzuki, Tomohiro Tanaka [...]

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy

Retricted access

Research article

First published 2022-6

A case of atezolizumab-associated tubulointerstitial nephritis

Elena V Zakharova, Tatyana A Makarova, Olga A Vorobyeva

Journal of Onco-Nephrology

Retricted access

Case report

First published 2018-6

Tubulitis in a patient treated with nivolumab: Case report and literature review

Viral Vakil, Mark Birkenbach, Katti Woerner [...]

Journal of Onco-Nephrology

Open access

Research article

First published 2020

Rationale and design of a phase II trial of durvalumab treatment in patients with NSCLC ineligible for stage III chemoradiotherapy following radiation monotherapy (SPIRAL-RT study)

Tadaaki Yamada, Junji Uchino, Yusuke Chihara [...]

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2019-12

Nivolumab-induced acute-onset type 1 diabetes mellitus as an immune-related adverse event: A case report

Yukihisa Hatakeyama, Hisashi Ohnishi, Kentaro Suda [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2017-03

Novel Treatment of Melanoma: Combined Parasite-Derived Peptide GK-1 and Anti-Programmed Death Ligand 1 Therapy

Jesus Vera-Aguilera, Armando Perez-Torres, Diego Beltran [...]

Cancer Biotherapy and Radiopharmaceuticals

Free access

Research article

First published 2022-11

Brain-derived programmed death-ligand 1 mediates immunosuppression post intracerebral hemorrhage

Nuo Cheng, Hong Wang, Ming Zou [...]

Journal of Cerebral Blood Flow & Metabolism

Open access

Review article

First published 2019

Immunotherapy for hepatocellular carcinoma: recent advances and future perspectives

Weiqi Xu, Ken Liu, Minjiang Chen [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2020

Current status of treatment with immune checkpoint inhibitors for gastrointestinal,hepatobiliary,and pancreatic cancers

Yuji Eso, Hiroshi Seno

Therapeutic Advances in Gastroenterology

Open access

Review article

First published 2019

Current Clinical Progress of PD-1/PD-L1 Immunotherapy and Potential Combination Treatment in Non–Small Cell Lung Cancer

Jia-Xin Li, Ju-Min Huang, Ze-Bo Jiang [...]

Integrative Cancer Therapies

Search results